Siemens Medical Solutions recently completed the EUR 4.2 billion ($5.5 billion) acquisition of Bayer Healthcare’s diagnostic division and merged it with Diagnostic Products Corp., creating Siemens Medical Solutions Diagnostics.

The new wholly owned subsidiary of Siemens Medical Solutions USA is headquartered in Tarrytown, New York, and in Los Angeles and employs more than 8,000 people.

“With the acquisitions of DPC and Bayer Diagnostics, we invested heavily in a future-oriented and growing market in the health care sector,” said Klaus Kleinfeld, CEO of Siemens AG. “We see tremendous potential for Siemens Medical Solutions Diagnostics, and have high expectations for the new unit.”

Siemens Medical Solutions Diagnostics has leading market positions in clinical chemistry, patient tests, laboratory automation and blood cell diagnostics. The new company offers a varied portfolio for the diagnosis and treatment of many illnesses such as pituitary or adrenal dysfunction, anemia, diabetes, reproductive and thyroid disorders, allergies, kidney ailments and infectious diseases, as well as for the fields of cardiology, oncology and virology.

 …